<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57245</article-id><article-id pub-id-type="doi">10.7554/eLife.57245</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-182790"><name><surname>Zhang</surname><given-names>Liyun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-182791"><name><surname>Chen</surname><given-names>Conan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182792"><name><surname>Fu</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182793"><name><surname>Lilley</surname><given-names>Brendan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182794"><name><surname>Berlinicke</surname><given-names>Cynthia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182795"><name><surname>Hansen</surname><given-names>Baranda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182796"><name><surname>Ding</surname><given-names>Ding</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182797"><name><surname>Wang</surname><given-names>Guohua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182798"><name><surname>Wang</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182799"><name><surname>Shou</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182800"><name><surname>Ye</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239942"><name><surname>Mulligan</surname><given-names>Timothy</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239943"><name><surname>Emmerich</surname><given-names>Kevin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182801"><name><surname>Saxena</surname><given-names>Meera T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239944"><name><surname>Hall</surname><given-names>Kelsi R</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182803"><name><surname>Sharrock</surname><given-names>Abigail V</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182804"><name><surname>Brandon</surname><given-names>Carlene</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60605"><name><surname>Park</surname><given-names>Hyejin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60604"><name><surname>Kam</surname><given-names>Tae-In</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47532"><name><surname>Dawson</surname><given-names>Valina L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2915-3970</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1665"><name><surname>Dawson</surname><given-names>Ted M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6459-0893</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182805"><name><surname>Shim</surname><given-names>Joong Sup</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182806"><name><surname>Hanes</surname><given-names>Justin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79786"><name><surname>Ji</surname><given-names>Hongkai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-22253"><name><surname>Liu</surname><given-names>Jun O</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3842-9841</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4485"><name><surname>Qian</surname><given-names>Jiang</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166901"><name><surname>Ackerley</surname><given-names>David F</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6188-9902</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182807"><name><surname>Rohrer</surname><given-names>Baerbel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-63622"><name><surname>Zack</surname><given-names>Donald J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21593"><name><surname>Mumm</surname><given-names>Jeff S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2575-287X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Wilmer Eye Institute</institution>, <institution>Johns Hopkins University</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biostatistics</institution>, <institution>Johns Hopkins University School of Public Health</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Johns Hopkins University School of Medicine</institution>, <addr-line><named-content content-type="city">Baltimore</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Victoria University of Wellington</institution>, <addr-line><named-content content-type="city">Wellington</named-content></addr-line>, <country>New Zealand</country></aff><aff id="aff5"><institution content-type="dept">Ophthalmology</institution>, <institution>Medical University of South Carolina</institution>, <addr-line><named-content content-type="city">Charleston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">School of Biological Science</institution>, <institution>Seoul National University</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff7"><institution content-type="dept">Faculty of Health Sciences</institution>, <institution>University of Macau</institution>, <addr-line><named-content content-type="city">Taipa</named-content></addr-line>, <country>Macao</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13465"><name><surname>Dowling</surname><given-names>James J</given-names></name><role>Reviewing editor</role><aff><institution>The Hospital for Sick Children</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jmumm3@jhmi.edu</email> (JM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e57245</elocation-id><history><date date-type="received"><day>26</day><month>03</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Zhang et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Zhang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57245-v1.pdf"/><abstract><p>Retinitis pigmentosa (RP) and associated inherited retinal diseases (IRDs) are caused by rod photoreceptor degeneration, necessitating therapeutics promoting rod photoreceptor survival. To address this, we tested compounds for neuroprotective effects in multiple zebrafish and mouse RP models, reasoning drugs effective across species and/or independent of disease mutation may translate better clinically. We first performed a large-scale phenotypic drug screen for compounds promoting rod cell survival in a larval zebrafish model of inducible RP. We tested 2,934 compounds, mostly human-approved drugs, across six concentrations, resulting in 113 compounds being identified as hits. Secondary tests of 42 high-priority hits confirmed eleven lead candidates. Leads were then evaluated in a series of mouse RP models in an effort to identify compounds effective across species and RP models, i.e., potential pan-disease therapeutics. Nine of eleven leads exhibited neuroprotective effects in mouse primary photoreceptor cultures, and three promoted photoreceptor survival in mouse <italic>rd1</italic> retinal explants. Both shared and complementary mechanisms of action were implicated across leads. Shared target tests implicated <italic>parp1</italic>-dependent cell death in our zebrafish RP model. Complementation tests revealed enhanced and additive/synergistic neuroprotective effects of paired drug combinations in mouse photoreceptor cultures and zebrafish, respectively. These results highlight the value of cross-species/multi-model phenotypic drug discovery and suggest combinatorial drug therapies may provide enhanced therapeutic benefits for RP patients.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Foundation Fighting Blindness</institution></institution-wrap></funding-source><award-id>Wynn-Gund TRAP</award-id><principal-award-recipient><name><surname>Mumm</surname><given-names>Jeff S</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30EY001765</award-id><principal-award-recipient><name><surname>Zack</surname><given-names>Donald J</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01EY019320</award-id><principal-award-recipient><name><surname>Rohrer</surname><given-names>Baerbel</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Department of Veterans Affairs</institution></institution-wrap></funding-source><award-id>RX000444 and BX003050</award-id><principal-award-recipient><name><surname>Rohrer</surname><given-names>Baerbel</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>South Carolina SmartState Endowment</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Rohrer</surname><given-names>Baerbel</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005640</institution-id><institution>Flight Attendant Medical Research Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Liu</surname><given-names>Jun O</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Liyun Zhang, has filed a provisional patent for the discoveries described herein..</p></fn><fn fn-type="conflict" id="conf3"><p>Jeff S Mumm, holds patents for the NTR inducible cell ablation system (US #7,514,595) and uses thereof (US #8,071,838 and US#8431768). Has filed a provisional patent for the discoveries described herein. All other authors have no commercial relationships..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies described herein were performed in accordance with both the Association for Research in Vision and Ophthalmology (ARVO) statement on the &quot;Use of Animals in Ophthalmic and Vision Research&quot; and the National Institutes of Health (NIH) Office of Laboratory Animal Welfare (OLAW) policies regarding studies conducted in vertebrate species. Animal protocols were approved by the Animal Care and Use Committees of the Johns Hopkins University School of Medicine (protocol # FI19M489 and #MO20M253) and Medical University of South Carolina (protocol #2018-00399).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source data files have been uploaded</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Miguel A. Moreno-Mateos</collab><collab>Charles E. Vejnar</collab><collab>Jean-Denis Beaudoin</collab><collab>Juan P. Fernandez</collab><collab>Emily K. Mis</collab><collab>Mustafa K. Khokha and Antonio J. Giraldez</collab></person-group><year iso-8601-date="2015">2015</year><source>CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo</source><ext-link ext-link-type="uri" xlink:href="https://www.crisprscan.org/">https://www.crisprscan.org/</ext-link><comment>CRISPRScan</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57245-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>